English Polski
Vol 15, No 1 (2022)
Case report
Published online: 2022-04-07

open access

Page views 4760
Article views/downloads 359
Get Citation

Connect on Social Media

Connect on Social Media

Acquired hemophilia A secondary to rheumatoid arthritis

Alan Majeranowski12, Filip Lebiedziński3, Izabela Topolewska4, Aleksandra Cegła3, Damian Palus5, Jakub Osowski3, Andrzej Mital1
Journal of Transfusion Medicine 2022;15(1):57-59.


Acquired hemophilia A (AHA) is a rare plasma diathesis. Unlike congenital hemophilia A, AHA occurs in both sexes and the incidence of the disease increases with age. It is caused by the production of autoantibodies against the coagulation factor VIII. AHA can be primary or secondary. The clinical course is characterized by a rapid development of symptoms, massive bleeding and high mortality. In the described case, a 69-year-old female was successfully treated for severe AHA with bypass-concentrate — recombinant activated factor VII and immunosuppressive therapy.

Article available in PDF format

View PDF Download PDF file

Journal of Transfusion Medicine